Do you want to meet with one of the most active Life Science investors in the World? Novo Ventures is the venture investment vehicle for Novo Holdings A/S – a holding and investment company that manages ~$45B of assets on behalf of the Novo Nordisk Foundation.
Novo Ventures is structured as an evergreen fund with an annual total of $350M to invest in private and public life science companies in North America and Europe. Their team identifies opportunities by leveraging a local presence in leading global biotech hubs and typically co-invests with other life sciences funds as either a lead or co-lead investor.
Novo Ventures has a strong focus on pre-commercial therapeutics and commercial med-tech companies, with opportunistic investments in diagnostics and research tools, and, more recently, digital health. Their team of professionals in Boston Copenhagen, London and San Francisco has an active portfolio of more than 50 companies and has invested in more than 140 companies since 2000.
For more information on Novo Ventures, visit http://www.novo.dk/ventures/about
Peter Moldt and Jennifer K. Lee from Novo Ventures will be in attendance to provide an overview presentation on Novo Ventures’ key areas of interest and venture investment philosophy. Novo Ventures will also be meeting 1-on-1 with select companies after the presentation.
CIC members use your code to enter for only $10!